NCT03369015View on ClinicalTrials.gov

Effect of D-amphetamine on Reward Functioning

PHASE1CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

January 24, 2018

Primary Completion Date

May 23, 2019

Study Completion Date

May 23, 2019

Conditions
Anhedonia
Interventions
DRUG

10 mg d-amphetamine

10 mg d-amphetamine dose given (double-blind) and behavioral tasks (EEfRT, PRT, ELT, CGT) administered.

DRUG

20mg d-amphetamine

20 mg d-amphetamine dose given (double-blind) and behavioral tasks (EEfRT, PRT, ELT, CGT) administered.

DRUG

Placebo

Placebo dose given (double-blind) and behavioral tasks (EEfRT, PRT, ELT, CGT) administered.

Trial Locations (1)

77030

The University of Texas Health Science Center at Houston, Houston

All Listed Sponsors
collaborator

Emory University

OTHER

lead

The University of Texas Health Science Center, Houston

OTHER

NCT03369015 - Effect of D-amphetamine on Reward Functioning | Biotech Hunter | Biotech Hunter